Latest Breaking News On - Neuromuscular diseases - Page 8 : comparemela.com

US Incidence, Prevalence of Myasthenia Gravis Rising

The incidence and prevalence of myasthenia gravis have increased in the United States, likely due to increased diagnosis and more awareness of the disease over time.

New havenUnited statesRichardj nowakAlexion pharmaceuticalsYale school of medicineAmerican academy of neurologyEma rodriguesAmerican academyYale myasthenia gravis clinicYale schoolMedscape medicalMyasthenia gravisMuscular atrophyUscular atrophiesRare diseasesElectronic medical record emr

Negligible Risk of Myasthenia Gravis Exacerbations After COVID-19 Vaccination

Patients with myasthenia gravis have a higher risk of COVID-19-associated emergency department visits, hospital admissions, and 30-day mortality, but vaccination acceptance rate was high among the population

Monica alcantaraUniversity of torontoEllen martin prosserman centre for neuromuscular diseasesUniversity health networkMartin prosserman centreNeuromuscular diseasesToronto general hospitalRisk reducedVaccination among individuals with myasthenia

Myasthenia Gravis Tied to Elevated Risk for Severe COVID

Patients with autoimmune disorder should be prioritized for vaccines, antivirals, researchers say

Ingrid heinOntario health insurance planCarolina barnettMartin prosserman centreNeuromuscular diseasesToronto general hospitalOntario health insuranceCharlson comorbidity indexMedpage today

Hansa Biopharma completes enrollment in phase 2 study of imlifidase in Guillain-Barré Syndrome (GBS)

Hansa Biopharma completes enrollment in phase 2 study of imlifidase in Guillain-Barré Syndrome (GBS)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United kingdomHansa biopharmaKlaus sindahlStephanie kenneyShahram attarianVp global corporate affairsInternational coordinating principal investigatorDrug administrationInternational guillain barrErasmus medical centreHead of department neuromuscular diseasesNasdaq stockholmSyndrome outcome studyNeuromuscular diseasesHopitaux universitaires de marseilleOrphan drug designation

Muscular Dystrophy Association Announces Nearly $400K in

New York, NY, March 13, 2023 (GLOBE NEWSWIRE) Today, Muscular Dystrophy Association (MDA) announced two research grants designed to address potential.

United statesNew yorkSan antonioDriscoll children hospitalBaylor college of medicineUniversity of texasCarrie miceliJeffrey chamberlainSharon hesterleeUniversity of california los angelesSchool of medicineInstitute for stem cell regenerative medicineChildren medical centerCare center networkUniversity of washingtonCook children medical center